Nano-X Imaging Ltd.
NASDAQ:NNOXMedical - Devices
Healthcare
$0.73 -1.45%
-$0.03 today
- Market cap
- $50.94M
- Beta
- 1.17
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$1.12
52W Low $1.59High $5.69
Volume 0.52M
Average 1.46M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$40.79M
FY 2025 · Annual
Investing Cash Flow
$29.37M
FY 2025 · Annual
Financing Cash Flow
$21.37M
FY 2025 · Annual
-45.9% YoYCash Flow Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (61.8M) | (105.24M) | (60.78M) | (53.52M) | (75.02M) |
| Depreciation & Amortization | 2.29M | 11.51M | 11.81M | 11.73M | 11.7M |
| Deferred Income Tax | (116K) | (3.73M) | (377K) | (377K) | (1.98M) |
| Stock-Based Compensation | 18.81M | 18.62M | 6.84M | 7.26M | 4.19M |
| Change in Working Capital | 2.75M | (16.95M) | (7.48M) | (1.13M) | 2.77M |
| Accounts Receivables | (40K) | 74K | (507K) | (321K) | 107K |
| Inventory | 864K | 0 | 0 | (277K) | (325K) |
| Accounts Payables | 1.72M | 469K | (153K) | (1.32M) | 288K |
| Other Working Capital | 202K | (17.49M) | (6.82M) | 787K | 2.7M |
| Other Non-Cash Items | (2K) | 52.4M | 5.21M | (572K) | 17.54M |
| Operating Cash Flow | (38.07M) | (43.39M) | (44.78M) | (36.6M) | (40.79M) |
| Capital Expenditures | (23.16M) | (7.17M) | (3.3M) | (2.77M) | (4.21M) |
| Acquisitions (Net) | (2.86M) | 1.01M | 0 | 0 | 0 |
| Purchases of Investments | (90.3M) | (9.46M) | (373K) | (58.52M) | (15K) |
| Sales of Investments | 90.3M | 31.24M | 39.11M | 41.19M | 33.8M |
| Other Investing Activities | (90.3M) | (1.01M) | (373K) | 46K | (200K) |
| Investing Cash Flow | (116.32M) | 14.61M | 35.43M | (20.05M) | 29.37M |
| Debt Repayment | 3.8M | 0 | 0 | 0 | 0 |
| Common Stock Issued | 3.58M | 949K | 27.14M | 37.83M | 21.37M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 3.58M | 804K | 113K | 1.67M | 0 |
| Financing Cash Flow | 7.38M | 804K | 27.25M | 39.5M | 21.37M |
| Effect of Forex Changes | (10K) | (268K) | (60K) | 72K | (101K) |
| Net Change in Cash | (147.01M) | (28.24M) | 17.85M | (17.07M) | 9.85M |
| Free Cash Flow | (61.23M) | (50.56M) | (48.08M) | (39.37M) | (45M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$75.0M
+ D&A$11.7M
+ Stock-Based Comp$4.2M
- Deferred Tax-$2.0M
+ Working Capital$2.8M
+ Other Non-Cash$17.5M
= Operating Cash Flow-$40.8M
- Capex-$4.2M
= Free Cash Flow-$45.0M
Analysis
FY2025 free cash flow is -$45.0M. FCF conversion is 60.0% of net income. Operating cash flow was -$40.8M, with capex of -$4.2M. The largest bridge item is Other Non-Cash at $17.5M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 6-K | 6-K filing | Sep 9, 2026 | |
| 6-K | 6-K filing | Aug 18, 2026 | |
| 6-K | 6-K filing | Aug 13, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 11, 2026 | |
| 424B5 | 424B5 filing | Aug 7, 2026 |
Does NNOX generate free cash flow?
Nano-X Imaging Ltd. (NNOX) generated -$45.00M of free cash flow in fiscal 2025.
How much operating cash flow does NNOX produce?
Operating cash flow was -$40.79M, before capital expenditures of $4.21M.
Continue the stock analysis
Jump to another research area for this company.